We’re Celebrating Clinical Trials Day!
Saturday 20th May is Clinical Trials Day, a day where the clinical research industry comes together to celebrate the value and importance it brings as
MAC Clinical Research is a full-service, global, pharmaceutical contract research organization (CRO), with science at the heart of everything we do. Read More…
Effective solutions to successfully deliver your clinical trials.
MAC conduct clinical trials for most of the worlds leading pharma and biotechs. Read More…
We offer an array of scientific solutions to support any clinical trial. Read More…
MAC’s flexible strategic consulting can support your project at any stage. Read More…
Saturday 20th May is Clinical Trials Day, a day where the clinical research industry comes together to celebrate the value and importance it brings as
Imagine living life with persistent pain that spreads throughout your body and feeling constantly drained. Fibromyalgia is a common condition and affects between 1.8 million
Read our white paper to find out more Last month we attended the 2023 CDISC Europe Interchange where MAC Principal SAS Programmer, Martyn Deverell, discussed
To continue to meet the research needs of our clients and their patients across the globe, MAC Clinical Research has arrived in Australia! As a
MAC enters partnership with Kariya Pharmaceuticals with the commencement of Phase I trial for Parkinson’s drug. We are excited to partner with Kariya Pharmaceuticals, a
Parkinson’s disease (PD) is a progressive movement disorder of the nervous system. Like a fingerprint, disease presentation is different in every person who receives a
At MAC, we welcome the recent update from the MHRA announcing that they will streamline clinical trial approvals in its biggest overhaul in 20 years.
Martyn Deverell, Principal SAS Programmer at MAC Clinical Research will be speaking at the 2023 CDISC Europe Interchange taking place in Copenhagen on 26 -27
As part of Rare Disease Day 2023, we want to highlight the work we are doing in Sickle cell disease. Sickle cell disease is the
We are excited to share that our Early Phase Unit in Manchester dosed the first participant in Small Pharma’s first-in-human Phase I clinical trial of
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |